Why light-sensing cells die in inherited retinal disorders
Mechanism of photoreceptor cell degeneration in animal models of retinal diseases
This research looks at how PRPH2 gene changes cause photoreceptors to break down in people with inherited retinal degeneration, aiming to guide future treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11377989 on NIH RePORTER |
What this research studies
From my perspective as a patient, the team uses animal models that carry the same PRPH2 changes seen in people to study how photoreceptor outer segments form and fall apart. They focus on how PRPH2 and its partner ROM1 shape the tiny membrane structures in rods and cones and map the other proteins that interact with PRPH2. The lab compares differences between rods and cones to explain why some cells die while others hold on, and they test how precise amounts of PRPH2 affect cell survival. Their findings are meant to point toward targets or strategies that could be developed into therapies down the road.
Who could benefit from this research
Good fit: People with inherited retinal degeneration linked to PRPH2 mutations—including certain forms of retinitis pigmentosa and macular/pattern dystrophies—would be most relevant to this research.
Not a fit: Patients whose vision loss stems from unrelated causes or from advanced, irreversible retinal scarring are unlikely to gain direct benefit from this basic lab-focused work.
Why it matters
Potential benefit: If successful, this work could identify molecular targets or dosing strategies that help prevent or slow vision loss from PRPH2-related inherited retinal diseases.
How similar studies have performed: Related animal-model studies have improved understanding of photoreceptor biology, but translating those findings into widely effective clinical treatments for PRPH2 disorders remains limited so far.
Where this research is happening
Houston, United States
- University of Houston — Houston, United States (Active)
Researchers
- Principal investigator: Naash, Muna I. — University of Houston
- Study coordinator: Naash, Muna I.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.